SHUBHAM PANT to Infusions, Intravenous
This is a "connection" page, showing publications SHUBHAM PANT has written about Infusions, Intravenous.
Connection Strength
0.046
-
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors. Cancer. 2015 Apr 01; 121(7):1056-63.
Score: 0.025
-
Cetuximab hypersensitivity infusion reactions: Incidence and risk factors. J Oncol Pharm Pract. 2013 Sep; 19(3):222-7.
Score: 0.022